Aarey Drugs & Pharmaceuticals

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue97.52134.65140.27120.25117.34
Expenses94.99131.73137.71118.97118.35
EBITDA2.532.922.561.28-1.01
EBIT2.132.422.060.69-1.42
Profit Before Tax2.733.122.201.980.80
Net Profit2.512.841.95-0.760.80
Financial Ratios
Operating Profit Margin2.59%2.17%1.83%1.06%-0.86%
Net Profit Margin2.57%2.11%1.39%-0.63%0.68%
Earning Per Share (Diluted)1.071.220.77-0.370.32
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI